Clinical Trials Sponsored by Guangzhou Gloria Biosciences Co., Ltd.

Total 660 results

Guangzhou Gloria Biosciences Co., Ltd.

Not yet recruiting

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

China
Guangzhou Gloria Biosciences Co., Ltd.

Unknown

Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma

Classical Hodgkin's Lymphoma

China
Guangzhou Gloria Biosciences Co., Ltd.

Recruiting

Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors

Solid Tumor

China
Guangzhou Gloria Biosciences Co., Ltd.

Not yet recruiting

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Persistent, Recurrent, or Metastatic Cervical Cancer

China
Guangzhou Gloria Biosciences Co., Ltd.

Not yet recruiting

GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)

Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Classic Hodgkin's Lymphoma
Guangzhou Gloria Biosciences Co., Ltd.

Recruiting

Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer (CC)

Cervical Cancer

China
Guangzhou Gloria Biosciences Co., Ltd.

Completed

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Sun Yat-sen University
Guangzhou Gloria Biosciences Co., Ltd.

Recruiting

A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Creative Biosciences (Guangzhou) Co., Ltd.

Completed

A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China

Neoplasms | Colorectal Neoplasms | Colorectal Cancer | Digestive System Neoplasm | Advanced Adenocarcinoma | Hyperplastic Polyp

China
Guangzhou Henovcom Bioscience Co. Ltd.

Recruiting

A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension

Parkinson's Disease

United States
Guangzhou Henovcom Bioscience Co. Ltd.

Completed

A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058

IPF

United States
Guangzhou Henovcom Bioscience Co. Ltd.

Completed

A Study of HNC664 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics

Healthy

United States
Guangzhou Henovcom Bioscience Co. Ltd.

Completed

A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics.

Healthy

United States
Creative Biosciences (Guangzhou) Co., Ltd.
Guangzhou Xiangkang Medical Research Co., Ltd.

Completed

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Pneumonia | Adenocarcinoma | Small Cell Lung Cancer | Chronic Obstructive Pulmonary Disease | Non-Small Cell Lung Cancer | Lung Cancer | Tuberculosis | Chronic Bronchitis | Squamous Cell Carcinoma | Lung Neoplasm | Respiratory Tract Infection | Acute Bronchitis | Adenosquamous Carcinoma | Large Cell Carcinoma | Sarcomatoid... and other conditions

China
Creative Biosciences (Guangzhou) Co., Ltd.
Guangzhou Xiangkang Medical Research Co., Ltd.

Recruiting

A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

Bladder Cancer | Urothelial Carcinoma | Urocystitis | Urinary Bladder Stone

China
Hangzhou Sciwind Biosciences Co., Ltd.

Recruiting

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

RSV Infection

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Type 2 Diabetes Mellitus | T2DM

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Weight Management

China
Hangzhou Sciwind Biosciences Co., Ltd.

Recruiting

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Healthy Volunteers

China
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Phase Ia Study of XW001 in Healthy Adult Subjects

Respiratory Syncytial Virus Infections

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Type 2 Diabetes Mellitus | T2DM

China
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (XW003)

Obesity | Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis

Australia
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Not yet recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Withdrawn

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

COVID-19 Acute Respiratory Distress Syndrome

Argentina, Peru
Guangzhou Henovcom Bioscience Co. Ltd.
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

Completed

A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics

Influenza

China
Anwita Biosciences
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Phase 1 First-in-human Study of JS014

Lymphoma | Solid Tumor, Adult | Neoplasm Malignant | Neoplasm, Experimental

Taiwan
Creative Biosciences (Guangzhou) Co., Ltd.
Dongguan Shipai Hospital

Completed

Retrospective Analysis of Colorectal Cancer Screening Results

Neoplasms | Colorectal Neoplasms | Colorectal Cancer | Digestive System Neoplasm | Advanced Adenocarcinoma | Hyperplastic Polyp

China
Shanghai Junshi Bioscience Co., Ltd.
Iqvia Pty Ltd; TopAlliance Biosciences, Inc.

Active, not recruiting

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Advanced Malignancies

United States
Hangzhou YuYuan Bioscience Technology Co., Ltd.
LG Chem

Completed

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

Infertility, Female

China
Guangzhou Institute of Respiratory Disease
Shanghai Junshi Bioscience Co., Ltd.

Unknown

Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance

IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy

China
Coherus Biosciences, Inc.
Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.

Active, not recruiting

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid Tumor

United States
Norroy Bioscience Co., LTD

Recruiting

A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC

Metastatic Castration-resistant Prostate Cancer

China
SK Bioscience Co., Ltd.

Completed

Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)

COVID-19 (Healthy Volunteers)

Korea, Republic of
SK Bioscience Co., Ltd.

Completed

Immunogenicity and Safety Study of NBP615 in Healthy Female

Cervical Cancer

Korea, Republic of
Norroy Bioscience Co., LTD

Recruiting

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients

Prostate Cancer

China
Norroy Bioscience Co., LTD

Recruiting

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

Clear Cell Renal Cell Carcinoma Metastatic

China
SK Bioscience Co., Ltd.

Completed

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

Influenza

Korea, Republic of
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors

Solid Tumors
Guangzhou Zhiyi Biotechnology Co., Ltd.

Completed

A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects

Chemotherapy-induced Diarrhea

United States
Guangzhou JOYO Pharma Co., Ltd

Completed

Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults

Healthy Subjects

China
Guangzhou JOYO Pharma Co., Ltd

Completed

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Idiopathic Pulmonary Fibrosis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Guangzhou Bioseal Biotechnology Co., Ltd.

Completed

Bioseal Dural Sealing Study BIOS-14-001

Malignant Tumors | Vascular Malformation | Benign Tumors

China
Guangzhou Wondfo Biotech Co., Ltd

Suspended

Preview Rapid Strep A Test Method Comparison Study

Strep Throat

United States
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

Chronic Hepatitis B

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Acute Upper Respiratory Infection

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Unknown

A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans

Arteriosclerosis Obliterans

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Unknown

The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B

Chronic Hepatitis B

China

Clinical Trials Sponsored by Guangzhou Gloria Biosciences Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations